← Scroll for more →
Forte Biosciences, Inc. (FBRX)
Pharmaceutical Preparations
Latest Price
$76.99
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
4.87
P/B Ratio
15.81
Institutional Ownership
93.9% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Federated Hermes, Inc. | 2.11M | $44.0M | 10.30% | +345.0K | 2026-06-30 |
| Orbimed Advisors LLC | 1.58M | $33.0M | 7.70% | +380.8K | 2026-06-30 |
| Fred Alger Management, LLC | 1.44M | $30.0M | 7.03% | +165.7K | 2026-06-30 |
| Jupiter Topco LLC | 1.37M | $29.0M | 6.70% | -- | 2026-06-30 |
| BlackRock, Inc. | 1.22M | $25.0M | 5.97% | +1.16M | 2026-06-30 |
| Mpm Bioimpact LLC | 987.4K | $20.0M | 4.82% | -13.2K | 2026-06-30 |
| TCG Crossover Management, LLC | 920.0K | $19.0M | 4.49% | -- | 2026-06-30 |
| Vanguard Capital Management LLC | 861.7K | $18.0M | 4.21% | +330.0K | 2026-06-30 |
| Woodline Partners LP | 712.8K | $15.0M | 3.48% | +380.8K | 2026-06-30 |
| Adage Capital Partners GP, L.L.C. | 700.0K | $14.0M | 3.42% | -250.0K | 2026-06-30 |